BACE1 and early-onset autosomal dominant Alzheimer disease: Tan X., Luo Y., Pi D., Xia L., Li Z., Tu Q. MiR-340 reduces the accumulationof amyloid-β through targeting BACE1 (β-site amyloidprecursor protein cleaving enzyme 1) in Alzheimer’s disease.